New approaches to acute pancreatitis: Role of inflammatory mediators

Digestion

Volumn 60, Issue SUPPL. 1, 1999, Pages 57-60

  Norman, James G ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Acute pancreatitis; Cytokines; Interleukin 1; Pancreas; Platelet activating factor; Therapy; Treatment; Tumor necrosis factor

Indexed keywords

ALCOHOL; CYTOKINE;

ACUTE PANCREATITIS; CONFERENCE PAPER; DISEASE SEVERITY; DISORDERS OF ACID BASE BALANCE; FEVER; GALLSTONE; HUMAN; INFLAMMATION; MEDIATOR; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; TACHYPNEA;

EID: 0033031126     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051455     Document Type: Conference Paper

References (3)

1. Norman J: The role of cytokines in the pathogenesis of acute pancreatitis (review). Am J Surg 1998;175:76-83.
2. Kingsnorth AN, Galloway SW, Formela LJ: Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995;82:1414-1420.
3. Norman J, Fink G, Denham W, et al: Tissue specific cytokine production during experimental acute pancreatitis: A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997:42:1783-1788.